Novo Nordisk A/S
LSE:0TDD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Novo Nordisk A/S
LSE:0TDD
|
DK |
|
Secom Co Ltd
F:XSC0
|
JP |
|
A
|
Axon Enterprise Inc
XBER:TCS
|
US |
|
K
|
Kohls Corp
DUS:KHP
|
US |
Wall St Price Targets
0TDD Price Targets Summary
Novo Nordisk A/S
According to Wall Street analysts, the average 1-year price target for 0TDD is 50.7555 USD with a low forecast of 27.6601 USD and a high forecast of 72.9567 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0TDD's stock price target?
Price Target
50.7555
USD
According to Wall Street analysts, the average 1-year price target for 0TDD is 50.7555 USD with a low forecast of 27.6601 USD and a high forecast of 72.9567 USD.
What is the Revenue forecast for Novo Nordisk A/S?
Projected CAGR
2%
Over the last 14 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for Novo Nordisk A/S?
Projected CAGR
-3%
Over the last 14 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 8 years is -3%.
What is the Net Income forecast for Novo Nordisk A/S?
Projected CAGR
-1%
Over the last 14 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 8 years is -1%.
